Wayfinding Financial, LLC Novo Nordisk A S Transaction History
Wayfinding Financial, LLC
- $228 Million
- Q1 2025
A detailed history of Wayfinding Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wayfinding Financial, LLC holds 657 shares of NVO stock, worth $45,411. This represents 0.02% of its overall portfolio holdings.
Number of Shares
657Holding current value
$45,411% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,837Shares Held
339MCall Options Held
12MPut Options Held
10.6M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.07 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$898 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$874 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$844 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...